Evaluating CTLA4 expression in BC by IHC, Yu and colleagues found that a high density of CTLA4-positive lymphocytes was an independent predictor of longer OS, while high expression of CTLA4 in tumor cells was a predictor of shorter OS, after controlling for clinicopathological variables including ER, PR, and HER2. This evidence concerns the gene CTLA4 and neoplasm.